FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2011/091/000006 [Registered on: 07/01/2011]
Last Modified On: 07/09/2011
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study
Modification(s)  
Nutraceutical 
Study Design  Other 
Public Title of Study
Modification(s)  
A Clinical study to evaluate the glycemic index of 4 rice samples in healthy volunteers 
Scientific Title of Study
Modification(s)  
A prospective, controlled, randomized, study to evaluate the glycemic index of 4 rice samples in healthy volunteers 
Trial Acronym  Nil 
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
SCR/001/2010  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  Dr Viral Shah 
Designation  Medical Director 
Affiliation  Spectrum Clinical Research Pvt. Ltd. 
Address  401, Kshamalaya Building
37, New Marine Lines
Mumbai
MAHARASHTRA
400020
India 
Phone  02240645101  
Fax  02266155567  
Email  vshah@spectrumcr.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr Viral Shah 
Designation  Medical Director 
Affiliation  Spectrum Clinical Research Pvt. Ltd. 
Address  401, Kshamalaya Building
37, New Marine Lines
Mumbai
MAHARASHTRA
400020
India 
Phone  02240645101  
Fax  02266155567  
Email  vshah@spectrumcr.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Dr Viral Shah 
Designation  Medical Director 
Affiliation  Spectrum Clinical Research Pvt. Ltd. 
Address  401, Kshamalaya Building
37, New Marine Lines
Mumbai
MAHARASHTRA
400020
India 
Phone  02240645101  
Fax  02266155567  
Email  vshah@spectrumcr.com  
 
Source of Monetary or Material Support
Modification(s)  
Marico Ltd., Rang Sharda, Krishnachandra Marg, Bandra Reclamation, Bandra (West), Mumbai - 400 050, India 
 
Primary Sponsor
Modification(s)  
Name  Marico Ltd 
Address  Rang Sharda, Krishnachandra Marg, Bandra Reclamation, Bandra (West), Mumbai - 400 050, India  
Type of Sponsor  Other [Consumer Products & Services Group] 
 
Details of Secondary Sponsor
Modification(s)  
Name  Address 
Spectrum Clinical Research Pvt Ltd  401, Kshamalaya Building, 37 New Marine Lines, Mumbai - 400020  
 
Countries of Recruitment
Modification(s)  
  India  
Sites of Study
Modification(s)  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Mr. Bharat Bhusan  Artemis Health Institute  Sector 51,-122001
Gurgaon
HARYANA 
09717211556
0124-6767701
clinicalresearch@artemishealthsciences.com 
Mr Sree Ganesh  Seventh Day Adventist Medical Center  Spencer Road,Frazer Town-560005
Bangalore
KARNATAKA 
09019949599
080-41626643
sreeganeshsg@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
ACE Ethics  Approved 
Artemis Health Sciences - IRB  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Healthy Human Volunteers  To find out glycemic index of given rice product 
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Comparator Agent  Glucon D  50 gm per day 
Intervention  Rice  50 gm per day 
 
Inclusion Criteria
Modification(s)  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1. Male or female subjects aged 18-45 years (both
inclusive), healthy (based on medical history),
2. Having BMI 18.5 ? 22.9
3. Fasting blood glucose levels below 100 mg/dl. 
 
ExclusionCriteria 
Details  1. Age below 18 or above 45 years 2. Body mass index below 18.5 or above 22.9 kg/m2 i.e. should not be obese. 3. Fasting blood glucose above 100 mg/dl 4. Family history of type 2 diabetes i.e. first and second order should not have diabetes. 5. History of any chronic disease or illness. 6. Any medication consumption in the past one week or suffering from any illness. 7. Any form of dieting or consumption of a special diet. 8. Smokers and heavy alcohol consumers. 9. Allergy to any food items served. 10. Pregnancy. 
 
Method of Generating Random Sequence
Modification(s)  
Other 
Method of Concealment
Modification(s)  
Other 
Blinding/Masking
Modification(s)  
Open Label 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
To evaluate the glycemic index of test food ( 4 rice
samples) 
Approximately 30 Days 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size
Modification(s)  
Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial
Modification(s)  
N/A 
Date of First Enrollment (India)
Modification(s)  
11/01/2011 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial
Modification(s)  
Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
This study is a prospective, controlled, randomized, study to evaluate the glycemic index of 4 rice samples in healthy volunteers that will be conducted in 2 centre in India. The objective of the study is to evaluate the glycemic index of test food ( 4 rice samples). The study is going to start in 2nd week of January 2011. 
Close